Next Science Limited

ASX (AUD): Next Science Limited (NXS)

Last Price

0.135

Today's Change

-0.007 (4.92%)

Day's Change

0.135 - 0.14

Trading Volume

10,699

Overview

Market Cap

39 Million

Shares Outstanding

292 Million

Avg Volume

201,220

Avg Price (50 Days)

0.17

Avg Price (200 Days)

0.26

PE Ratio

-1.69

EPS

-0.08

Earnings Announcement

27-Jan-2025

Previous Close

0.14

Open

0.14

Day's Range

0.135 - 0.14

Year Range

0.115 - 0.5

Trading Volume

10,699

Price Change Highlight

1 Day Change

-4.93%

5 Day Change

-12.90%

1 Month Change

8.00%

3 Month Change

-40.00%

6 Month Change

-48.08%

Ytd Change

-61.97%

1 Year Change

-48.08%

3 Year Change

-89.11%

5 Year Change

-94.62%

10 Year Change

-90.00%

Max Change

-90.00%

News and Blogs
Latest Hottest Following

No result.

Company Profile

Sector: Healthcare - Healthcare

Industry: Drug Manufacturers—Specialty & Generic

Description:

Next Science Limited, a medical technology company, researches, develops, and commercializes technologies that address the impacts of biofilms in human health in the United States and Australia. The company develops its products using Xbio Technology platform. It offers SURGX, an antimicrobial gel designed for surgical infection management; BACTISURE, a wound lavage that is used to remove biofilm; BlastX, an antimicrobial wound gel that destroys bacteria within the gel and defends from recolonization while maintaining a moist wound environment; and XPERIENCE, an no rinse antimicrobial solution that helps prevent surgical site infections. Next Science Limited was founded in 2012 and is headquartered in Chatswood, Australia.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment